Join our community of smart investors

Simon Thompson's venture for accelerated earnings growth

This healthcare specialist is backed by fund managers to deliver a step change in profitability.
Simon Thompson's venture for accelerated earnings growth

When a company with a relatively fixed cost base has capacity to increase sales, the impact on margins can be dramatic as a higher proportion of incremental revenue is converted into operating profit. That's exactly what's on offer with the company in my latest report as its manufacturing business scales up production from both third-party contract work and brings production in-house from the earnings accretive acquisitions the company is making. 

Moreover, a cashed-up balance sheet is set to be deployed on further acquisitions, offering the prospect of significant earnings upgrades. Trading on a 2020 forward cash-adjusted price/earnings (PE) ratio of 12, and rated on a material ratings discount to rivals, the shares are primed for a sharp re-rating over the next 12 months. 

Download PDF
To continue reading...
Subscribe to Alpha Today and You’ll Get
  • Unlimited access to all of our content
  • Phil Oakley’s round up of companies and updates on his Fantasy Sipp portfolio
  • Broker style company research notes from our small cap expert Simon Thompson
  • Quality, Momentum, Growth at Reasonable Price (GARP) and Dividend Yield stock screens
  • Algy Hall’s monthly value-momentum investment trust screen and portfolio of diverse closed-end funds
Have an account? Sign in